NJ Bio Inc
Healthcare
09 December, 2024
Advent-owned Suven Pharma to buy majority stake in NJ Bio for $64 mn
Private equity giant Advent International-owned contract development and manufacturing organization (CDMO) Suven Pharma ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News